JAN
Janone IncNASDAQINDUSTRIALSWASTE MANAGEMENT
Key Statistics
Market Cap
$27.14M
P/E Ratio
—
EPS
$-4.40
Beta
2.16
52W High
$0.00
52W Low
$0.00
50-Day MA
$2.40
200-Day MA
$1.79
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Janone Inc
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for pain management. The company is headquartered in Las Vegas, Nevada.
Fundamentals
| Revenue (TTM) | $39.61M |
| Gross Profit (TTM) | $7.62M |
| EBITDA | $-3.73M |
| Operating Margin | 0.00% |
| Return on Equity | -104.10% |
| Return on Assets | -12.70% |
| Revenue/Share (TTM) | $11.15 |
| Book Value | $-0.56 |
| Price-to-Book | 6.35 |
| Price-to-Sales (TTM) | 0.13 |
| EV/Revenue | 0.652 |
| EV/EBITDA | -1.27 |
| Quarterly Earnings Growth (YoY) | -98.90% |
| Quarterly Revenue Growth (YoY) | -29.10% |
| Shares Outstanding | $12.17M |
| Float | $8.74M |
| % Insiders | 0.93% |
| % Institutions | 5.32% |
Data last updated: 4/8/2026